Menlo, CA, United States of America

Dennis G Ballinger

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Biotechnology Methods. Top assignees: Hyseq, Inc., University of Cambridge, Bgi-Shenzhen Co., Limited. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis G Ballinger. Retrieved from https://idiyas.com/inventor/dennis-g-ballinger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 50.0

 

 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 77(Granted Patents)


Location History:

  • Menlo, CA (US) (2002)
  • Menlo Park, CA (US) (2002 - 2019)
  • Pleasanton, CA (US) (2024)

Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Analyte Detection
Breast Cancer Markers
Nucleic Acid Sequencing
Growth Factor Antagonists
Polynucleotides
Interleukin-1
Materials and Methods
FGFAn-Hy
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Dennis G Ballinger

Introduction

Dennis G Ballinger is a notable inventor based in Menlo, California, with a remarkable portfolio of 12 patents. His work primarily focuses on advancements in the field of breast cancer diagnosis and treatment, showcasing his commitment to improving healthcare outcomes.

Latest Patents

Among his latest patents, Ballinger has developed innovative markers for breast cancer, providing correlations between polymorphisms and the disease. He has also created methods for diagnosing, prognosing, and treating breast cancer, along with systems and kits designed for these purposes. Additionally, he has described methods for identifying breast cancer modulators. Another significant patent involves an isolated oligonucleotide used in nucleic acid sequencing, which features a unique double-stranded structure that enhances the sequencing process.

Career Highlights

Throughout his career, Dennis G Ballinger has made significant contributions to the field of biotechnology. He has worked with reputable companies such as Hyseq, Inc. and Cambridge Enterprise Limited, where he has applied his expertise to develop groundbreaking technologies.

Collaborations

Ballinger has collaborated with esteemed colleagues, including David R Cox and Bruce Ponder, further enriching his research and innovation efforts.

Conclusion

Dennis G Ballinger's contributions to breast cancer research and biotechnology exemplify his dedication to innovation and improving patient care. His extensive patent portfolio reflects his significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…